In prostate cancer, aberrant DNA methylation patterns have been associated with disease aggressiveness and poor prognosis, while deregulated noncoding RNAs, such as microRNAs and long noncoding RNAs, have been shown to modulate AR signaling and other oncogenic pathways [10, 11]. The gene discussed is AR; the disease is Familial prostate cancer.